Top 50 Dna Data Storage in Asia

This startup develops an end-to-end integrated microfluidics chip that uses CRISPR-based DNA editing to write, read, and store digital data in bacterial DNA. This technology offers researchers a novel method for high-density, long-term data storage and retrieval.

GENOBOTICS AI provides a cloud‑native platform that applies deep‑learning models to automatically annotate genomic variants and predict their therapeutic relevance. Users upload standard formats (VCF, BAM, FASTQ) and receive batch‑processed results within minutes via RESTful APIs or an interactive dashboard, with end‑to‑end encryption and HIPAA/GDPR compliance for pharmaceutical, biotech, and academic precision‑medicine teams.

Helix integrates genomic data into healthcare systems, enabling health organizations to utilize population genomics for personalized diagnosis, treatment, and prevention. By providing actionable genetic insights, Helix enhances patient outcomes and reduces costs across medical research and clinical care.

3BIGS utilizes bio big data and AI-driven platforms to analyze next-generation sequencing (NGS) data, identifying patterns, mutations, and biomarkers for drug discovery and healthcare insights. The company addresses the challenge of extracting actionable information from vast biological datasets, accelerating the development of targeted therapies and improving patient outcomes.

OneCell.Ai provides an AI‑enhanced single‑cell multi‑omics platform that integrates DNA, RNA, and protein analysis from tissue or liquid biopsies into a single assay, delivering real‑time, actionable genomic insights for cancer care. Its suite of branded tests—including OncoIndx®, OncoIndx® Prime+, OncoRisk®, OncoTarget®, and OncoHRD®—offers comprehensive profiling of somatic and germline mutations, gene fusions, pharmacogenomics, and HRD scores to support targeted therapy selection, immunotherapy eligibility, resistance monitoring, and clinical‑trial matching.

Cambrian Bioworks develops nucleic acid extraction technologies and tools for molecular diagnostics and life science research, enhancing workflow efficiency in applications such as sequencing and genotyping. Their products, including the Manta system, address the complexities of sample preparation and handling, making genomics more accessible and affordable.

Provides genetic testing services using next-generation sequencing and proprietary algorithms to detect hereditary diseases, cancer mutations, and genetic disorders. These tests enable early diagnosis, personalized treatment plans, and risk assessment, improving health outcomes for patients in prenatal, oncology, and chronic disease contexts.

Algorithmic Biologics develops a software platform that enhances molecular testing workflows through advanced computational applications, including compression algorithms for next-generation sequencing. This technology significantly reduces library preparation costs by over 60%, making molecular diagnostics more accessible and efficient for healthcare providers.

Nalagenetics offers genetic testing services utilizing microarray and qPCR technology to provide personalized health insights tailored to the Southeast Asian population. Their tests identify genetic predispositions related to nutrition, fitness, and medication compatibility, enabling individuals to make informed health decisions and optimize their wellness.

The startup develops biomarker-driven targeted therapies that focus on cell cycle regulation, DNA damage response, and previously undruggable cancer targets. This approach enables oncologists to provide more effective treatment options tailored to the specific genetic profiles of tumors, improving patient outcomes in cancer care.

Igentify Ltd offers a digital platform that streamlines genomic workflows, enabling patients, laboratories, and healthcare providers to access and interpret genetic information securely. This solution addresses the challenge of inefficient genetic data management, enhancing the effectiveness of preventive healthcare services.

Infinidat provides a data storage software platform capable of managing and protecting multiple petabytes of data through advanced data reduction and replication techniques. This solution addresses the challenges of data scalability and security for enterprises with large-scale storage needs.

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

Ghostdrive provides secure data storage and sharing solutions through client-side encryption and decentralized storage, ensuring that users maintain control over their sensitive information. By utilizing computed storage technology, Ghostdrive optimizes data management, allowing users to store significantly more content without requiring additional space.

Geneyx provides DNA and RNA data analysis and interpretation for whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, enabling rapid transformation of raw genetic data into clinical reports. The platform enhances diagnostic accuracy and efficiency, aiming to eliminate undiagnosed diseases by increasing the diagnostic yield and reducing turnaround times for genetic testing.

bitBiome utilizes single-cell sequencing technology to catalog and evolve microbial genomes, creating a diverse database of over 2 billion sequences. This platform addresses the need for unique enzymes and proteins to enhance biomanufacturing processes across various industries, including drug production and sustainable materials development.

MGI Tech develops genetic sequencers and lab automation tools that enhance genomic analysis and streamline sample preparation processes in life sciences. Their technology addresses the need for efficient, high-throughput sequencing and data management, enabling precise diagnostics and research in healthcare and agriculture.

Identifai Genetics provides an early‑stage, non‑invasive prenatal screening that analyzes fetal cell‑free DNA from a simple maternal blood draw in the first trimester. Their proprietary bioinformatics pipeline digitally isolates fetal DNA from the mixed maternal‑fetal sample, reconstructs the fetal genome at high resolution, and detects a wide range of genetic conditions—from single‑gene mutations to chromosomal anomalies—delivering a comprehensive clinical report for obstetricians and genetics specialists.

This startup provides a Kubernetes-native storage solution specifically designed for AI workloads, utilizing a new architecture that combines NVMe and object storage to enhance data management and distribution. It addresses the bottleneck in AI performance by offering storage that is eight times faster and 3.5 times cheaper than existing cloud block storage options, without requiring changes to existing infrastructure.

The startup develops a genotyping and sequencing platform that translates genetic data into clinical applications, enabling healthcare providers to make informed treatment decisions. This technology enhances patient care and biomedical research by improving the understanding and management of diseases.

This startup produces plant-based food products using functional plant ingredients and DNA analysis to create alternatives to traditional dairy items. Their offerings, including plant-based milk and eggless mayonnaise, provide consumers with healthier options while reducing reliance on animal products.

This startup offers whole genome sequencing and genetic testing services to identify health risks and inform personalized medicine. They provide genetic counseling and bioinformatics tools to patients and healthcare providers for accurate genetic analysis.

Zene is a genome data analysis platform that offers high-precision genomic analysis services using saliva samples to provide individuals with insights into their genetic traits. The platform also supports health insurance organizations by delivering actionable genomic information to reduce medical costs and enhance employee health management.

CrisprBits develops intelligent molecular platforms powered by CRISPR technology for applications across healthcare, food safety, and sustainability. The company offers scalable solutions including PathCrisp for rapid diagnostics, EdiCrisp for precision genome engineering, and CurieCrisp for preclinical disease modeling. These platforms aim to deliver cost-effective innovations in diagnostics, gene editing, and strain engineering sectors.

Logomix offers a Geno-Writing platform that enables precise engineering of megabase-scale genomic sequences in human cells, facilitating the creation of custom cell types with specific functions. This technology addresses the challenges of immune rejection and functional integration in cell therapies, enhancing the development of advanced regenerative medicine solutions.

Autotelic Bio develops antisense oligonucleotide (ASO) therapeutics that bind to disease‑specific mRNA transcripts, blocking translation and reducing harmful protein production. Their platform designs custom DNA strands for injectable delivery, enabling precise, rapid development of treatments for genetic, neurodegenerative, and other protein‑mediated disorders. The company targets pharma, biotech, and research organizations seeking nucleic‑acid‑based drug solutions.

The startup provides genomic reports tailored for the Indian population by integrating genomic, physiological, and physical data through machine learning algorithms. This approach enables individuals to understand their genetic predispositions and make informed decisions about their diet and lifestyle to mitigate the risk of lifestyle and clinical disorders.

One BioMed offers the Xceler8™ Solution, an automated platform for nucleic acid extraction and purification that utilizes a patented reversible-crosslinking method for efficient sample processing. This technology addresses the need for streamlined and accessible molecular research tools, enabling faster and more reliable biomedical testing across various applications.

MxT Biotech develops the Hydroporator®, a non-viral microfluidic platform for efficient delivery of cargos like DNA, mRNA, and proteins into primary cells. This technology offers high delivery efficiency, viability, and scalability, avoiding limitations associated with viral transduction or electroporation. The platform supports advancements in cellular engineering, genome editing, and cancer immunotherapy research and manufacturing.

Pixel Biosciences specializes in the synthesis of customized RNA and DNA reagents, including sgRNA and CRISPR gene editing tools, utilizing their proprietary nMECA technology to significantly reduce impurities in mRNA synthesis. Their solutions enhance the precision and efficiency of gene editing and drug development processes in research and clinical applications.

This startup operates a data science studio that utilizes full-stack technology for data collection, storage, analysis, and utilization to help businesses leverage big data. By transforming underutilized data into actionable insights, the company enables organizations to make informed predictions and drive value creation.

Natural Trace provides a food‑grade DNA‑based tagging system that embeds a traceable marker directly into food products. The accompanying rapid detection kit and cloud platform enable precise authentication, regulatory compliance, and supply‑chain visibility. This solution helps manufacturers protect intellectual property, build consumer trust, and mitigate food fraud risk.

The startup has developed a decentralized multichain storage platform that utilizes unused storage capacity from individual computers to create a distributed hosting network. This approach enhances data security and provides a cost-effective alternative to traditional cloud services while allowing users to earn cryptocurrency by sharing their storage space.

GeneStory provides comprehensive genetic sequencing and analysis services utilizing proprietary algorithms and a reference database of Vietnamese genomes. The company delivers personalized health reports covering disease risk, drug response (pharmacogenomics), nutrition, and physical potential. This data enables individuals to optimize their lifestyle, nutrition, and preventative healthcare strategies.

The startup offers a blockchain technology platform that enables decentralized applications to utilize multi-chain data co-storage and cross-chain data management with a focus on data privacy protection. This platform addresses the limitations of traditional storage services by providing unlimited scalability and secure data storage solutions for users.

Regene Genomics provides predictive diagnostics through genetic testing, enabling individuals to understand their genetic predispositions and make informed health decisions. The company focuses on delivering accurate test results while ensuring data privacy and fostering transparent communication with clients.

The startup provides biotechnology research and development services focused on the genomic editing of fertilized eggs using the electroporation method, enabling high-throughput production of genetically modified mice. This technology supports clients in the creation and commercialization of genetically modified mouse models for research and therapeutic applications.

This startup provides an AI-powered blockchain platform for decentralized science, specifically focused on genomics. It offers researchers access to clean, labeled, and organized genetic profiles, accelerating the development of personalized, data-driven medical solutions and reducing time-to-market for genomics-based AI applications.

Foresee Genomics provides comprehensive next-generation sequencing (NGS) solutions, including protocols, reagents, and bioinformatics tools, to make high-accuracy genomic analysis accessible to smaller laboratories. Their technology enables labs to perform rapid, accurate diagnostics with minimal investment and small sample requirements. This accessibility accelerates timely genomic testing, supporting precision medicine and enhancing patient care outcomes.

Avecris develops the SPRING DNA technology platform to create a new class of programmable genetic medicines. This platform enables sustained, cell-type specific gene expression for delivering therapeutic proteins with long-lasting effects. The technology overcomes prior limitations in gene delivery, allowing for redosable, immune-quiet, non-integrating gene cargo of any size.

This biotechnology company offers genetic testing services, including DNA methylation analysis, to help individuals understand their biological age, telomere length, and rate of aging. By providing insights into these key longevity markers, the company enables customers to make informed decisions to improve their health and well-being.

ComputeGenomics provides specialized, high-performance computing (HPC) platforms tailored for accelerating large-scale genomics data analysis. The platform utilizes CPU/GPU-based approaches to rapidly process complex genomic studies such as variant calling, genotyping, and single-cell analysis. They deliver integrated, on-premise hardware solutions with scalable storage and dedicated administrative support for secure data management.

This startup provides a bioinformatics platform that analyzes single-cell genomic data to help researchers understand disease mechanisms. It offers accessible, expert data analysis tools, enabling clients to advance genomic research for personalized medicine.

BDX is an auction house that facilitates the liquidity and fair price discovery of distributed data storage solutions through a decentralized marketplace. This platform enables permissionless transactions of data services and assets, addressing the need for a robust data economy in the Web3 ecosystem.

Twogene is a contract development and manufacturing organization (CDMO) specializing in the process development and large-scale production of plasmid DNA (pDNA) and proteins for the cell and gene therapy industry. The company addresses the need for GMP-compliant manufacturing by providing fast-turnaround production capabilities, ranging from research-grade to large-scale GMP-grade batches, ensuring high-quality outputs for preclinical, clinical, and commercial applications.

Advanx Health utilizes personal genomics to provide customized health insights based on individual DNA analysis, enabling users to understand their genetic predispositions and health risks. This approach allows users to create tailored health plans that address specific needs, moving away from generic wellness solutions.

Supagene offers direct-to-consumer DNA testing with a specialized focus on Asian genomes, providing personalized health and wellness insights. Their microarray-based testing delivers highly accurate genetic data for over 300 health and trait markers, complemented by expert genetic counseling.

CareXera Health Sdn. Bhd. offers personalized predictive DNA and epigenetic profiling to identify health risks and optimize lifestyle interventions for chronic disease prevention and healthy longevity. The company also provides tailored learning and development strategies for children through genetic and fingerprint profiling, enhancing their unique talents and addressing their nutritional needs.

The startup develops nucleic acid-based adjuvants and primers for PCR genetic testing, utilizing blocker-based oligonucleotide synthesis technology to produce high-purity oligonucleotides at scale. This capability enables pharmaceutical companies to enhance the development of therapeutics by providing reliable and efficient nucleic acid APIs.

Magee offers the PAL platform, which combines ID‑POS technology with its Ameba DNA AI engine to instantly identify shoppers via card scans and generate real‑time individual preference profiles. The system delivers one‑to‑one coupons and campaigns through an in‑store touch‑screen terminal with on‑demand printing, while providing cloud‑based analytics that track footfall, purchase behavior, and loyalty metrics for retail chains.